UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Sequential Cytarabine and α-Particle Immunotherapy with Bismuth-213-Lintuzumab (HuM195) for Acute Myeloid Leukemia

Clinical cancer research, 2010-11, Vol.16 (21), p.5303-5311

2010

Volltextzugriff (PDF)

Phase I Evaluation of J591 as a Vascular Targeting Agent in Progressive Solid Tumors

Clinical cancer research, 2007-05, Vol.13 (9), p.2707-2713

2007

Volltextzugriff (PDF)

Intraperitoneal alpha-particle radioimmunotherapy of ovarian cancer patients: pharmacokinetics and dosimetry of (211)At-MX35 F(ab')2--a phase I study

The Journal of nuclear medicine (1978), 2009-07, Vol.50 (7), p.1153

2009

Volltextzugriff (PDF)

In vitro and in vivo characterization of 177Lu-huA33: a radioimmunoconjugate against colorectal cancer

Nuclear medicine and biology, 2006-11, Vol.33 (8), p.991-998

2006

Volltextzugriff (PDF)

Monoclonal antibody-based therapy for renal cell carcinoma

Urologic Clinics of North America, 2003-08, Vol.30 (3), p.623-631

2003

Volltextzugriff (PDF)

Whole-body clearance kinetics and external dosimetry of 131I-3F8 monoclonal antibody for radioimmunotherapy of neuroblastoma

Health physics (1958), 2007-01, Vol.92 (1), p.33-39

2007

Volltextzugriff (PDF)

Current Status of Therapy of Solid Tumors

The Journal of nuclear medicine (1978), 2005-01, Vol.46 (1 suppl), p.141S-50S

2005

Volltextzugriff (PDF)

Editorial: what ails solid tumor radioimmunotherapy?

Cancer biotherapy & radiopharmaceuticals, 2006-04, Vol.21 (2), p.81-84

Divgi, Chaitanya

2006

Volltextzugriff (PDF)

New strategies in radioimmunotherapy for lymphoma

Current oncology reports, 2003-09, Vol.5 (5), p.364-371

2003

Volltextzugriff (PDF)

PET-based compartmental modeling of (124)I-A33 antibody: quantitative characterization of patient-specific tumor targeting in colorectal cancer

European journal of nuclear medicine and molecular imaging, 2015-10, Vol.42 (11), p.1700-1706

2015

Volltextzugriff (PDF)

Targeted therapy of renal cell carcinoma: Synergistic activity of cG250‐TNF and IFNg

International journal of cancer, 2009-07, Vol.125 (1), p.115-123

2009

Volltextzugriff (PDF)

Monoclonal antibody therapy of kidney cancer

Cancer treatment and research, 2003, Vol.116, p.199

2003

Volltextzugriff (PDF)

Pharmacokinetic Model of Iodine-131-G250 Antibody in Renal Cell Carcinoma Patients

The Journal of nuclear medicine (1978), 1998-03, Vol.39 (3), p.484-489

1998

Volltextzugriff (PDF)

Active and passive immunotherapy: vaccines and antibodies

BJU international, 2007-05, Vol.99 (5b), p.1301-1304

2007

Volltextzugriff (PDF)

Phase I/II radioimmunotherapy trial with iodine-131-labeled monoclonal antibody G250 in metastatic renal cell carcinoma

Clinical cancer research, 1998-11, Vol.4 (11), p.2729-2739

1998

Volltextzugriff (PDF)

Targeting Lewis Y (Ley) in Small Cell Lung Cancer with a Humanized Monoclonal Antibody, hu3S193: A Pilot Trial Testing Two Dose Levels

Journal of thoracic oncology, 2007-10, Vol.2 (10), p.947-952

2007

Volltextzugriff (PDF)

The value of gamma camera and computed tomography data set coregistration to assess Lewis Y antigen targeting in small cell lung cancer by (111)Indium-labeled humanized monoclonal antibody 3S193

European journal of radiology, 2008-08, Vol.67 (2), p.292

2008

Volltextzugriff (PDF)

A phase 1B trial of humanized monoclonal antibody M195 (anti-CD33) in myeloid leukemia : specific targeting without immunogenicity

Blood, 1994-04, Vol.83 (7), p.1760-1768

1994

Volltextzugriff (PDF)

Phase I/II study of iodine 131-labeled monoclonal antibody A33 in patients with advanced colon cancer

Journal of clinical oncology, 1994-08, Vol.12 (8), p.1561-1571

1994

Volltextzugriff (PDF)

Status of radiolabeled monoclonal antibodies for diagnosis and therapy of cancer

Oncology (Williston Park, N.Y.), 1996-06, Vol.10 (6), p.939

Divgi, C R

1996

Volltextzugriff (PDF)

A phase I trial of monoclonal antibody M195 in acute myelogenous leukemia: specific bone marrow targeting and internalization of radionuclide

Journal of clinical oncology, 1991-03, Vol.9 (3), p.478-490

1991

Volltextzugriff (PDF)

Phase I Clinical Trial with Fractionated Radioimmunotherapy Using 131I-Labeled Chimeric G250 in Metastatic Renal Cancer

The Journal of nuclear medicine (1978), 2004-08, Vol.45 (8), p.1412

2004

Volltextzugriff (PDF)

A performance evaluation of 90Y dose-calibrator measurements in nuclear pharmacies and clinics in the United States

Applied radiation and isotopes, 2008-02, Vol.66 (2), p.252-260

2008

Volltextzugriff (PDF)

Targeting osseous metastases: rationale and development of radio-immunotherapy for prostate cancer

Current oncology reports, 2004-05, Vol.6 (3), p.222-229

2004

Volltextzugriff (PDF)

Murine and humanized constructs of monoclonal antibody m195 (anti‐cd33) for the therapy of acute myelogenous leukemia

Cancer, 1994-02, Vol.73 (S3), p.1049-1056

1994

Volltextzugriff (PDF)

1 – 25 von 28

Suche als RSS-Feed

Aktive Filter

ThemaAntibodies, Monoclonal - Therapeutic Use

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(28)
Mit Volltextzugriff
(23)

Publikationsform

Artikel
(28)

Sprache

Englisch
(28)

Erscheinungsjahr

n.n

Thema

Humans
(28)
Life Sciences & Biomedicine
(16)
Science & Technology
(16)
Female
(15)
Male
(14)
Middle Aged
(13)
Adult
(12)
Aged
(12)
Radioimmunotherapy
(11)
Radioimmunotherapy - Methods
(11)
Antibodies, Monoclonal - Pharmacokinetics
(10)
Oncology
(10)
Antibodies, Monoclonal - Adverse Effects
(9)
Biological And Medical Sciences
(9)
Medical Sciences
(9)
Iodine Radioisotopes - Therapeutic Use
(8)
Animals
(6)
Antineoplastic Agents
(6)
Iodine Radioisotopes - Pharmacokinetics
(6)

14 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Sequential Cytarabine and α-Particle Immunotherapy with Bismuth-213-Lintuzumab (HuM195) for Acute Myeloid Leukemia

Phase I Evaluation of J591 as a Vascular Targeting Agent in Progressive Solid Tumors

Intraperitoneal alpha-particle radioimmunotherapy of ovarian cancer patients: pharmacokinetics and dosimetry of (211)At-MX35 F(ab')2--a phase I study

In vitro and in vivo characterization of 177Lu-huA33: a radioimmunoconjugate against colorectal cancer

Monoclonal antibody-based therapy for renal cell carcinoma

Whole-body clearance kinetics and external dosimetry of 131I-3F8 monoclonal antibody for radioimmunotherapy of neuroblastoma

Current Status of Therapy of Solid Tumors

Editorial: what ails solid tumor radioimmunotherapy?

New strategies in radioimmunotherapy for lymphoma

PET-based compartmental modeling of (124)I-A33 antibody: quantitative characterization of patient-specific tumor targeting in colorectal cancer

Targeted therapy of renal cell carcinoma: Synergistic activity of cG250‐TNF and IFNg

Monoclonal antibody therapy of kidney cancer

Pharmacokinetic Model of Iodine-131-G250 Antibody in Renal Cell Carcinoma Patients

Active and passive immunotherapy: vaccines and antibodies

Phase I/II radioimmunotherapy trial with iodine-131-labeled monoclonal antibody G250 in metastatic renal cell carcinoma

Targeting Lewis Y (Ley) in Small Cell Lung Cancer with a Humanized Monoclonal Antibody, hu3S193: A Pilot Trial Testing Two Dose Levels

The value of gamma camera and computed tomography data set coregistration to assess Lewis Y antigen targeting in small cell lung cancer by (111)Indium-labeled humanized monoclonal antibody 3S193

A phase 1B trial of humanized monoclonal antibody M195 (anti-CD33) in myeloid leukemia : specific targeting without immunogenicity

Phase I/II study of iodine 131-labeled monoclonal antibody A33 in patients with advanced colon cancer

Status of radiolabeled monoclonal antibodies for diagnosis and therapy of cancer

A phase I trial of monoclonal antibody M195 in acute myelogenous leukemia: specific bone marrow targeting and internalization of radionuclide

Phase I Clinical Trial with Fractionated Radioimmunotherapy Using 131I-Labeled Chimeric G250 in Metastatic Renal Cancer

A performance evaluation of 90Y dose-calibrator measurements in nuclear pharmacies and clinics in the United States

Targeting osseous metastases: rationale and development of radio-immunotherapy for prostate cancer

Murine and humanized constructs of monoclonal antibody m195 (anti‐cd33) for the therapy of acute myelogenous leukemia

Aktive Filter

Suchergebnisse filtern